201
Participants
Start Date
March 19, 2018
Primary Completion Date
May 28, 2023
Study Completion Date
May 28, 2023
Tranexamic Acid
Investigational product given within 2 hours of symptom onset
Normal saline
Placebo given within 2 hours of symptom onset
National Taiwan University Hospital, Taipei
Royal Prince Alfred Hospital, Camperdown
Liverpool Hospital, Liverpool
John Hunter Hospital, New Lambton Heights
Alfred Hospital, Melbourne
Mobile Stroke Unit, Parkville
St Vincent's Hospital Melbourne, Fitzroy
Austin Hospital, Heidelberg
Box Hill Hospital, Box Hill
Monash Medical Centre, Clayton
University Hospital Geelong, Geelong
Princess Alexandra Hospital, Woolloongabba
Gold Coast University Hospital, Southport
Palmerston North Hospital, Palmerston North
Sunshine Coast University Hospital, Birtinya
Royal Adelaide Hospital, Adelaide
Wellington Hospital, Wellington
CDHB Christchurch Hospital, Christchurch
China Medical University Hospital, Taichung
Royal Melbourne Hospital, Melbourne
Helsinki University Hospital, Helsinki
E-DA Hospital, Kaohsiung City
Bach Mai Hospital, Hanoi
Military 103 Hospital, Hanoi
Nguyen Tri Phuong Hospital, Ho Chi Minh City
Lead Sponsor
The Florey Institute of Neuroscience and Mental Health
OTHER
Neuroscience Trials Australia
OTHER